Company ProfilePremium

Momentum Group Limited (formerly Momentum Metropolitan Holdings Limited)

Company Profile Analysis

Ticker: MTM.JO

ESOMAR 23 Corporate BadgeISO Certifications Badge
Momentum Group Limited - Company showcase

Year Founded & Workforce

2000

14,300 Employees

Momentum Group Limited logo

Momentum Group Limited Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Momentum Group Limited Overview

Momentum Group is one of South Africa's largest diversified insurance and financial services groups. It earns profits across life insurance, investment and savings platforms, employee benefits, specialist non-life insurance, and healthcare administration. Its multi-brand model separates the affluent-market Momentum franchise from the mass-market Metropolitan brand, and adds Guardrisk, South Africa's leading cell-captive and alternative-risk-transfer insurer. Momentum Health is now the country's second-largest medical scheme administrator after taking over Bonitas Medical Fund in June 2026. Outside South Africa, the group has a shrinking but more profitable African footprint (Namibia, Botswana, Lesotho), a UK investment manager (MGIM), and a 44.1% stake in India's Aditya Birla Health Insurance. Under CEO Jeanette Marais's Impact strategy (FY2025–FY2027), the group delivered record normalised headline earnings of R7.06bn and a 21.7% ROE in FY2026, a year early. Value of new business remains the main gap against its own targets.


What the company does

Momentum Group sells and administers financial protection, savings, retirement and investment products, and healthcare administration services, to individuals, employers, retirement funds, medical schemes and corporate risk owners. Earnings come from three broad sources:

  1. Life insurance margins. These are the release of the IFRS 17 contractual service margin (CSM), risk adjustment release, and experience variances (mortality, morbidity, persistency, expenses) on protection, annuity and savings business written by Momentum Retail, Metropolitan Life, Momentum Corporate, Momentum Investments (annuities) and Momentum Africa. The group CSM was R20.4bn at 30 June 2025 and R20.99bn at 31 March 2026 (FY2025 results SENS; Q3 FY2026 operating update).

  2. Fee and platform income. This is asset-based fees on the Momentum Wealth platforms, asset management and multi-management (Momentum Investments, MGIM), administration and managed-care fees (Momentum Health), cell-captive management fees (Guardrisk), and umbrella fund administration (Momentum Corporate's FundsAtWork). Momentum Investments reported assets under administration of R581bn and assets under management of R611.5bn at end-FY2026 (FY2026 results as reported by Moonstone, 21 September 2026).

  3. Non-life underwriting results. These come from Momentum Insure (personal and commercial short-term insurance) and Guardrisk General Insurance and Guardrisk Life (underwriting on the group's own balance sheet plus cell-captive arrangements).

Shareholders also earn an investment return on shareholder capital: R779m in FY2025 and about R1.09bn in FY2026 (FY2025 SENS; FY2026 results per Moonstone).

Company's own description

The company describes itself as one of South Africa's largest diversified financial services groups. It offers protection (life and non-life), investment, long-term savings and healthcare administration through its client-facing brands Momentum, Metropolitan and Guardrisk, with Eris as its property brand (paraphrased from Profile's Stock Exchange Handbook entry and company materials). It names financial advice as its key differentiator, and uses technology to support advisers while keeping a human touch (FY2025 results outlook statement, paraphrased).

Independent characterisation

Revenue model componentDescriptionIndicative share of FY2026 NHE (derived)
Life insurance margins (recurring-premium protection, annuities, group risk)Momentum Retail, Metropolitan Life, Momentum Corporate, annuity book in Momentum Investments, Momentum AfricaMajority (Retail + Metropolitan + Corporate + Africa ≈ 56% of NHE)
Platform and asset-management feesMomentum Wealth, MGIM, multi-management, collective investmentsEmbedded in Momentum Investments (16.9% of NHE, together with annuities)
Administration fees (healthcare and retirement)Momentum Health (GEMS, Bonitas, Momentum Medical Scheme), FundsAtWork administrationMomentum Health 5.2% plus part of Corporate
Non-life underwriting and cell-captive feesGuardrisk, Momentum Insure≈ 21% (Guardrisk 14.7% + Insure 6.7%)
Associate earningsAditya Birla Health Insurance (44.1%)0.3% (first profit in FY2026)

On revenue model, Momentum is overwhelmingly a service and risk-carrying business. There is no product manufacturing in the industrial sense, no material licensing revenue, and only quasi-subscription income (recurring premiums and medical scheme administration fees). A practical revenue-model split, inferred from FY2025–FY2026 NHE composition and not a company disclosure, is:

On value chain position, Momentum is vertically integrated from product manufacture (underwriting) through distribution and administration. It has tied advice channels (Momentum Financial Planning, the Metropolitan agency force), an IFA-support network (Consult by Momentum), a broker distribution arm (Momentum Distribution Services), and in-house administration. The FY2026 interim results noted that Momentum Financial Planning's vertical integration produced nine times higher net flows into Momentum solutions, rising to R1.2bn, and that Consult's assets under administration grew 25% to R59bn (IOL Business Report, 19 March 2026).

On customer types, the group serves:

  • Affluent and middle-income individuals (Momentum brand).

  • Lower- and middle-income households (Metropolitan brand: funeral, protection, savings).

  • Employers and retirement funds (Momentum Corporate).

  • Medical schemes and their members (Momentum Health: GEMS, Bonitas, Momentum Medical Scheme; about 4m health beneficiaries per the MML debt investor roadshow 2026).

  • Corporates, affinity partners, retailers and banks (Guardrisk cell captives).

  • Policyholders in Namibia, Botswana and Lesotho, and Indian retail health insurance customers through ABHI.

End-markets are South African long-term insurance, retirement and savings, asset management, short-term insurance, healthcare administration and managed care, sub-Saharan African insurance, Indian health insurance, and UK multi-asset investment management.

Strategy

Stated strategy: Impact strategy (F2025–F2027)

The Impact strategy, launched in 2024, aims to position Momentum as a leading South African insurer. It rests on enablers labelled People, Transformation, Digital, Sustainability and Capital deployment (company Impact strategy materials). The main themes, paraphrased from company results statements and investor presentations, are:

  1. Advice as differentiator. Deepen client relationships through financial adviser channels, with technology supporting advisers while keeping a human touch.

  2. Accountable business units. Units are empowered and measured on output and impact, and each targets profitable growth.

  3. Profitable growth and VNB focus. Grow sales volumes and market share in profitable products. VNB is explicitly named the "main area of concern".

  4. Efficiency. A group-wide performance-optimisation programme (R810m annualised savings by end-FY2026), policy administration system consolidation, and AI and automation.

  5. Disciplined capital deployment. Allocate capital only where returns justify it, pursue value-adding bolt-on acquisitions, and distribute surplus capital through dividends and buybacks.

  6. Group collaboration. Examples: collaboration between Momentum Health and Momentum Corporate added 30,000 members, and vertical integration of tied advice raised net flows into Momentum solutions.

Medium-term financial targets (F2027 ambitions, published 23 July 2024)

TargetF2027 ambitionFY2025 actualFY2026 actualStatus
Normalised headline earningsR7bnR6.26bnR7.06bnAchieved a year early
Return on equity20%21.2%21.7%Achieved
VNB margin1%–2%0.6%0.5%Not achieved; the company calls VNB its main concern
Dividend payout40%–60% of NHE (revised Sept 2025, target midpoint 50%)44% of 2H NHE43%Within range, at the lower end

The group expects to disclose its next strategic plan, covering the period to FY2030, within the next 12 months (FY2026 results, per Moonstone).

Strategic initiatives in the last 24 months (October 2024 – October 2026)

InitiativeDateDescriptionTargets / outcome
Group performance optimisation programmeFY2025–FY2026Group-wide cost and productivity programmeR810m annualised savings by FY2026 year-end; direct expense growth held to 3%
Metropolitan Life channel optimisation and turnaroundFY2024–FY2026Smaller, more productive agency force; focus on new business quality; system migrationVNB from −R13m to +R60m; margin from −0.2% to 1.1%; NHE R1.15bn
Momentum Insure underwriting and claims-procurement optimisationFY2025–FY2026Claims procurement cost optimisation, lead quality, broker tooling (Control)Combined ratio from 90% to 88%
Bonitas administration contractAwarded Jan 2026; live 1 Jun 2026Largest medical scheme administrator transfer in South AfricaAdministration market share from 22% to 30%
GEMS contract extensionReported Mar 2026Five-year extension of the main administrator contractSecures the largest health administration client
Africa operating model reviewCompleted FY2025; changes effective FY2026Restructured Africa operating model; exits from Ghana and the Mozambique entityAfrica NHE R387m, Botswana and Lesotho turnarounds
Capital managementFY2025–FY2026R2bn buybacks to Sept 2025; further R1bn completed April 2026; R1.5bn subordinated debt May 2026Shares bought at discounts to EV
Revised dividend policySept 2025Payout range raised from 33–50% to 40–60% of NHE; FY2026 specifies a 50% targetDPS +40% (FY2025), +31% (FY2026)
AI and automationFY2026Seven AI use cases generated R40m savings (H1 FY2026); plan to deepen AI use in FY2027Ongoing
Product relaunches to reduce onerous contractsFY2025–FY2026Repricing and relaunching products that were onerous at inceptionOnerous contracts down 39% from R570m to R349m
Guardrisk bolt-onsDates not disclosedAcquisitions of Zestlife and Admed (gap cover)Guardrisk NHE above R1bn
Verso acquisitionEffective 1 Sep 2026Retirement fund administration and consultingScale in Corporate administration
SustainabilityF2024 onward23% absolute emissions reduction by 2030 vs 2019 (Scope 1, 2, operational Scope 3); CDP B (2025)See Section 20

Products & Services

Product-level specifications, launch years and pricing are generally not disclosed by South African insurers in financial filings.

Momentum Retail (Momentum Life / Momentum Advice and Distribution)

OfferingDescriptionTarget customerLaunch / latest versionPricing model
Momentum protection (risk) rangeIndividual life, disability, critical illness and income protection cover. Long-dated protection cash flows make this book sensitive to the ultimate spot-rate assumption (a R320m negative market variance in FY2026 after the assumption was cut from 10% to 9.3%).Middle and affluent individuals—Risk premiums; underwriting-based
Investo (long-term savings)Long-term savings product; FY2026 enhancements drove VNB growthMiddle and affluent saversEnhanced in FY2026Asset-based and policy fees (not disclosed)
Momentum MultiplyRewards and wellness programme linked to Momentum productsMomentum policyholders—Programme fees not disclosed; the group's capital-deployment slide references Multiply capital use
Momentum Financial Planning (MFP)Tied advice forceRetail clientsOngoingCommission/fee
Consult by MomentumIndependent adviser network; AUA up 25% to R59bn (H1 FY2026)IFAsOngoingNetwork/support fees not disclosed
Momentum Distribution Services (MDS)Broker distributionBrokersOngoing—
Momentum MoneyTransactional/money proposition; appears as a capital consumer in the CMD capital-deployment slideRetail——

Momentum Investments

OfferingDescriptionTarget customerLaunch / latest versionPricing model
Momentum Wealth (local platform)Linked investment service provider (LISP) platform; Wealth new business +24% in FY2026Retail investors via advisers—Asset-based platform fees
Momentum Wealth InternationalOffshore platform (products domiciled including Guernsey)Offshore investors—Asset-based fees
Guaranteed life annuitiesAnnuities with guaranteed income for life; volumes −26% in FY2026RetireesOngoingPriced on yields and mortality
Living annuitiesMarket-linked drawdown annuities; volumes +14% in FY2026RetireesOngoingAsset-based fees
Back-to-back productsStructured products repriced in FY2026Retail / institutional——
Momentum Asset ManagementSingle-manager asset managementInstitutional / retailOngoingAUM fees
Momentum Outcome-based Solutions; Momentum Multi-Manager; Momentum Investment Consulting; Momentum Collective Investments; Momentum Alternative InvestmentsMulti-management, consulting, CIS and alternatives businesses (listed in the 2023 Stewardship Report as discretionary AUM components)Institutional / retailOngoingAUM fees
Momentum Global Investment Management (MGIM)UK multi-asset manager; acquired Seneca IM (2020) and Crown Agents IM (2023)UK advisers, DFMs, institutions, international clientsOngoingAUM fees
Momentum SecuritiesSecurities/stockbroking business, noted for growth in the 2026 strategy updateRetail investors—Brokerage fees
Student Accommodation Impact Investment FundImpact fund that added over 5,000 student beds (2024 Stewardship Report)Institutional——

Metropolitan Life

OfferingDescriptionTarget customerLaunch / latest versionPricing model
Funeral coverIndividual and family funeral plansLower- and middle-income householdsOngoingMonthly premiums
Protection (life cover)Mass-market life cover; products relaunched to reduce onerous contractsMass marketRelaunches in FY2025–FY2026Monthly premiums
Savings and investment plansLong-term savings productsMass marketOngoingPremium/fee based
AnnuitiesLife annuity productsRetirees in the mass marketOngoingYield/mortality pricing
DistributionTied agency (reduced 42% FY2024–FY2026), telesales, brokers; adviser productivity up from 2.8 to 3.7 policies a week———

Momentum Corporate

OfferingDescriptionTarget customerLaunch / latest versionPricing model
FundsAtWorkUmbrella retirement fund (savings and protection components); described as one of the market's largestEmployers (SME to large)OngoingAdministration and asset fees
Group riskEmployer-paid life, disability and funeral coverEmployersOngoingGroup risk premiums
Structured investments; single-premium institutional dealsLarge single-premium investment mandatesRetirement funds and institutionsOngoingFees/spreads
With-profit and guaranteed annuitiesInstitutional annuity business (main CSM driver in Corporate)Retirement fundsOngoingYield/mortality pricing
Continuation assuranceIn-force portfolio; heavier mortality hurt FY2026Former group membersIn-forcePremiums
Verso (from 1 Sep 2026)Retirement fund administration, benefits consulting, healthcare broking, wealth management, trustee servicesEmployers and fundsAcquired 2026Fees

Momentum Health

OfferingDescriptionTarget customerLaunch / latest versionPricing model
Medical scheme administration: GEMSMain administrator of the Government Employees Medical Scheme; contract extended for another five years (reported March 2026)Public-sector employeesExtension reported 2026Administration and managed-care fees
Medical scheme administration: BonitasFull administration services from 1 Jun 2026 (managed care went to PHA); adds over 750,000 beneficiaries; more than 600 staff; 17 dedicated service centresBonitas membersGo-live 1 Jun 2026Administration fees
Momentum Medical Scheme administrationAdministration of the group-aligned open schemeMembersOngoingFees
Health4MeAffordable health product with continued growthLower-income employees—Monthly premiums
Capitation contractsRisk-sharing contracts; favourable claims experience in FY2026Schemes / employersOngoingCapitation fees

Guardrisk

OfferingDescriptionTarget customerLaunch / latest versionPricing model
First-party cell captivesCorporates self-insure through ring-fenced cellsLarge corporatesOngoingManagement fees plus share of underwriting
Third-party (affinity) cell captivesRetailers, banks and brands distribute insurance under cells (Capitec's credit life book moved out in 2024)Distribution partnersOngoingFees
Guardrisk General Insurance (GGI)Conventional corporate and commercial insurer (including the Inniu property underwriting team); FY2026 underwriting result +26% to R828mCorporate/commercialOngoingPremiums
Guardrisk LifeLife cells and underwriting; FY2026 underwriting result rose from R45m to R244mPartnersOngoingPremiums/fees
Admed gap coverMedical gap cover sold through accredited advisers; 2026 retail family premiums R620/month (Supreme) and R500/month (Primary)Medical scheme members2026 versionMonthly premiums (published)
ZestlifeGap cover business acquired by Guardrisk (acquisition date not disclosed in sources reviewed)Medical scheme members—Monthly premiums

Momentum Insure

OfferingDescriptionTarget customerLaunch / latest versionPricing model
Personal lines (motor, home, contents)Short-term cover through advisers and direct channelsMiddle/affluent householdsOngoingPremiums
Commercial linesSmall business coverSMEsOngoingPremiums
Control broker platformAssets of insurtech Control acquired for R28m to improve quotation delivery to independent brokersBrokersFY2026—

Momentum Africa

CountryStatusLines
NamibiaLargest contributor (earnings −17% in FY2026)Life, health, asset management, pensions administration
BotswanaTurnaround in FY2026Life and related
LesothoTurnaround in FY2026; corporate protection growthLife and related
MozambiqueMomentum Mozambique Limitada sold 31 Aug 2026; the company says this is not necessarily a full exitNon-life / related
GhanaExited 9 Sep 2025 (sale to emPLE Group)—

India: Aditya Birla Health Insurance (ABHI, 44.10%)

OfferingDescriptionNotes
Retail and group health insuranceA "health-first" wellness-led health insurer; one of India's standalone health insurersFirst positive full-year IFRS 17 contribution to Momentum NHE in FY2026 (R22m)
Momentum Services (India)Group digital and AI capability based in India, cited in the 2026 Impact strategy update as adding valueLocation and headcount not disclosed

Eris Property Group

Property management and development brand. It manages properties including retail centres in the shareholder and policyholder portfolios (2020 integrated report references solar installations at Eris-managed malls).

Financial Narrative

Applicability note

Momentum Group is an insurance group reporting under IFRS 17. "Gross profit", "EBITDA", "capex", "working capital", "current ratio" and "cash conversion cycle" are not meaningful for an insurer and are not disclosed. The group's primary performance measures are normalised headline earnings (NHE), operating profit (NHE excluding investment return on shareholder funds), the contractual service margin (CSM), value of new business (VNB), embedded value (EV) and SAM solvency cover. The tables below follow that architecture. Unavailable cells are blank.

Earnings (5 years)

Sources: FY2022–FY2023 IFRS 4 from FY2023 results SENS (13 Sep 2023) and company media release; FY2023 restated, FY2024 and FY2025 from FY2024 and FY2025 results SENS; FY2026 from FY2026 results via Moonstone, Business Day and Daily Investor.

Per-share data (5 years)

Discrepancy flag: the restated FY2023 NHEPS was shown as 228.0c in the September 2024 trading statement (based on interim restatements) and 235.2c in the final FY2024 results. The 235.2c figure is used here.

Growth rates and CAGR

NHE CAGR, FY2024–FY2026 (IFRS 17 basis): 26.1% (R4,438m to R7,060m).

NHE CAGR, FY2023 restated–FY2026 (IFRS 17 basis): 26.3% (R3,491m to R7,060m).

NHEPS CAGR, FY2023 restated–FY2026: 31.0% (235.2c to 530.0c). Per-share growth exceeds earnings growth because of buybacks.

DPS CAGR, FY2022–FY2026: 23.1% (100c to 230c).

Revenue CAGR: Not computable. Multi-year IFRS 17 insurance revenue was not available in the sources reviewed.

Margins and returns

Notes: - The FY2026 ROEV of 22.3% is from Daily Investor's report of the FY2026 results, which also cites a FY2025 comparative of 17.9%. The company's FY2025 SENS reported ROEV per share of 19.1%. The difference probably reflects total-EV vs per-share bases; both are shown as reported.

  • Payout ratios are derived as DPS ÷ NHEPS using the basis in force for each year (IFRS 4 for FY2022–FY2023). The company reported a 43% payout for FY2026.

  • An "EBITDA margin" or "gross margin" is not applicable to an insurer.

New business

FY2026 PVNBP of R93.8bn is a rounded media figure (+18%). The company noted that PVNBP growth benefited from lower opening discount yields. CSM was R20,989m at 31 March 2026 (Q3 FY2026 operating update); the FY2026 closing CSM was not available in the sources reviewed.

Balance sheet

FY2024 total assets restated per FY2025 AFS. The H1 FY2026 interim showed restated 30 June 2025 comparatives of R803,213m total assets and R770,259m total liabilities.

FY2026 year-end EV per share and solvency cover were not available in the sources reviewed. Interim data points:

EV per share R44.55 at 31 December 2025: - MML solvency cover 1.76x at 30 September 2025, 1.64x at 31 December 2025 and 1.81x at 31 March 2026, against a target range of 1.6–2.0x.

The group target range is 1.35–1.65x: Debt and other items

Total debt: Third-party data (Simply Wall St, based on FY2025 statements) shows total debt of R10.2bn, a debt-to-equity ratio of 30.9% (down from 50% five years earlier) and interest coverage of 6.5x. The company's own definition and breakdown of borrowings (subordinated debt vs other) were not available in the sources reviewed. A further R1.5bn of subordinated debt was raised on 19 May 2026.

  • Short/long split, net debt, goodwill and intangibles, working capital: Not available in the sources reviewed. "Cash and short-term investments" of R747.5bn in third-party data reflects policyholder assets and is not a meaningful liquidity measure for an insurer.

Cash flow and capital returns

Buyback detail: - FY2023: R500m (27.9m shares at an average R17.87, a 43% discount to EV), completed 31 May 2023.

  • FY2024 to early FY2026: R2bn of programmes completed by 12 September 2025. These were the R1bn announced at FY2024 results and the R1bn announced at FY2025 interim results. The second R1bn bought 29.1m shares at an average R34.42 (19% discount to EV of R42.51).

  • FY2026: 45m shares for R1.6bn in total during the financial year. This includes the R1bn programme of 27.4m shares at an average R36.45, completed 8 April 2026.

  • Operating cash flow, capex and free cash flow are not disclosed in a comparable form for an insurer. The group reports "cash earnings" and dividend inflows from subsidiaries. The CMD finance presentation shows cumulative dividend inflows to Momentum Group of R12.6bn over F2022–F2024 as reported on that slide.

Ratios

ROIC, current ratio, net debt/EBITDA, asset turnover and cash conversion cycle are not meaningful for an insurer and are not disclosed.

Commentary on trends, inflections and drivers

FY2022–FY2023: post-Covid recovery under IFRS 4.

  • FY2023 IFRS 4 NHE reached a then-record R5.1bn, helped by fading Covid mortality and favourable yield-curve-driven investment variances.

  • Management itself guided that the underlying run-rate was closer to R4bn a year.

  • That caution was justified: the IFRS 17 restatement cut FY2023 NHE to R3.49bn.

  • The change mainly reflects the IFRS 17 shift to deferring new business profits into the CSM, rather than recognising them upfront, plus other restatements.

FY2024: reset year.

  • NHE grew 27% to R4.44bn on the new basis.

  • Metropolitan Life struggled with high lapse rates.

  • Momentum Insure lost about R300m on severe weather claims and service and integration problems (FY2024 results call, as summarised by GuruFocus).

  • The Impact strategy and F2027 ambitions were set in July 2024 when ROE was 15.5%.

FY2025: inflection.

  • NHE jumped 41% to R6.26bn and ROE reached 21.2%, already above the 20% F2027 target.

  • Drivers were higher CSM release from a larger CSM balance, strong annuity profits in Momentum Investments, better new business profitability and persistency in Metropolitan Life, favourable mortality and morbidity in Momentum Corporate's group risk book, and a turnaround in Momentum Insure (R192m to R438m).

  • Positive assumption changes and favourable yield-curve shifts also helped, which means part of the earnings came from the market.

  • VNB fell 20% because guaranteed annuity volumes dropped and Corporate's mix shifted away from FundsAtWork.

FY2026: target reached a year early.

  • NHE rose 13% to R7.06bn, and every business unit was profitable for the first time.

  • Quality of earnings improved: operating profit rose 9% while market variances fell 67%.

  • Investment return on shareholder funds rose 40% to about R1.09bn.

  • The R810m annualised performance-optimisation savings held direct expense growth to 3%, below inflation.

  • Momentum Retail (−26%) absorbed a R320m negative market variance from the lower ultimate spot-rate assumption.

  • Momentum Corporate (−12%) saw lower reserve releases and heavier continuation-assurance mortality.

  • Buybacks lifted NHEPS 18% against 13% NHE growth.

  • VNB rose only 5% on 18% higher PVNBP, and the margin compressed to 0.5% against a 1–2% target.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Segment Overview

SegmentWhat it containsKey products/services

Momentum Retail

Individual life and savings for middle and affluent markets

Risk/protection, long-term savings (Investo), Multiply rewards; tied and IFA advice

Momentum Investments

Investment platforms, asset/multi-management, annuities, UK investment management

Momentum Wealth (local/international), guaranteed and living annuities, MGIM, back-to-back products

Metropolitan Life

Mass-market life insurance

Funeral, protection, savings, annuities; agency, telesales and broker channels

Momentum Corporate

Employee benefits and institutional

FundsAtWork umbrella funds, group risk, structured investments, with-profit and guaranteed annuities, continuation assurance; Verso (from Sep 2026)

Momentum Health

Healthcare administration and managed care

Administration of GEMS, Bonitas (from 1 Jun 2026), Momentum Medical Scheme; Health4Me; capitation contracts

Guardrisk

Specialist and cell-captive insurance

First- and third-party cell captives, Guardrisk General Insurance, Guardrisk Life, gap cover (Admed, Zestlife)

Momentum Insure

Personal and commercial short-term insurance

Motor, home and contents, small commercial

Momentum Africa

Operations outside South Africa in Africa

Namibia (largest), Botswana, Lesotho; Ghana exited Sep 2025; Mozambique entity sold Aug 2026

India

44.10% equity-accounted stake in ABHI

Retail and group health insurance in India

Shareholders

Group capital, central costs, investment return on shareholder funds

—

Revenue by Segment

Segment NHE (ZAR Mn)FY2024FY2025FY2026

Momentum Retail

1,1091,3561,010

Momentum Investments

5339631,190

Metropolitan Life

5958681,148

Momentum Corporate

1,1821,6181,420

Momentum Health

255295367

Guardrisk

6537751,040

Momentum Insure

192438474

Momentum Africa

376288387

India

-274-6722

Shareholders segment

-183-274—

Group NHE

4,4386,2607,060

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Revenue by Segment (%)

Contribution to group NHE (%)FY2024FY2025FY2026

Momentum Retail

25.021.714.3

Momentum Investments

12.015.416.9

Metropolitan Life

13.413.916.3

Momentum Corporate

26.625.820.1

Momentum Health

5.74.75.2

Guardrisk

14.712.414.7

Momentum Insure

4.37.06.7

Momentum Africa

8.54.65.5

India

-6.2-1.10.3

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Segment NHE growth (%)

Segment NHE growth (%)FY2025FY2026

Momentum Retail

22-26

Momentum Investments

8124

Metropolitan Life

4632

Momentum Corporate

37-12

Momentum Health

1615

Guardrisk

1926

Momentum Insure

1288

Momentum Africa

-2379

Group NHE

4113

Operating profit (ZAR Mn)

Operating profit (ZAR Mn)FY2024FY2025

Momentum Retail

9071,192

Momentum Investments

450897

Metropolitan Life

476760

Momentum Corporate

9961,449

Momentum Health

255295

Guardrisk

668797

Momentum Insure

59291

Momentum Africa

-27-89

India

-275-69

Shareholders segment

99-42

Group operating profit

3,6085,481

Investment return on shareholder funds (ZAR Mn)

Investment return on shareholder funds (ZAR Mn)FY2024FY2025

Momentum Retail

202164

Momentum Investments

8366

Metropolitan Life

119108

Momentum Corporate

186169

Guardrisk

-15-22

Momentum Insure

133147

Momentum Africa

403377

India

12

Shareholders segment

-282-232

Group investment return

830779

Segment Revenue

SegmentIndicatorFY2025FY2026

Momentum Insure

Claims ratio (%)

5147

Momentum Insure

Expense ratio (%)

3941

Momentum Insure

Combined ratio (%)

9088

Momentum Corporate

Target underwriting margin (net of tax)

5–7% (company target; UK roadshow)

—

Metropolitan Life

New business margin (%)

-0.21.1

Momentum Retail

New business margin (%)

0.51.0

Momentum Investments

New business margin (%)

1.00.6

Momentum Africa

New business margin (%)

-0.6-0.3

“—” = not publicly disclosed.

Earnings metric

Earnings metricFY2022FY2023FY2024FY2025FY2026

NHE IFRS 4 basis (ZAR Mn)

4,3835,079———

NHE IFRS 17 basis (ZAR Mn)

—3,4914,4386,2607,060

Operating profit IFRS 4 basis (ZAR Mn, approx)

3,4004,400———

Operating profit IFRS 17 basis (ZAR Mn)

——3,6085,4815,970

Investment return on shareholder funds (ZAR Mn)

——8307791,090

Earnings attributable IFRS 17 basis (ZAR Mn)

——3,8475,9786,810

Headline earnings IFRS 17 basis (ZAR Mn)

——4,0616,002—

Insurance revenue (ZAR Mn)

————61,400

Net insurance and investment result (ZAR Mn)

————18,330

Per-share metric (ZAR cents)

Per-share metric (ZAR cents)FY2022FY2023FY2024FY2025FY2026

NHEPS IFRS 4 basis

287.2342.3———

NHEPS IFRS 17 basis

—235.2309.7451.0530.0

HEPS IFRS 4 basis

297.3310.7———

HEPS IFRS 17 basis (basic)

—215.5298.6446.9528.7

Diluted HEPS IFRS 17 basis

—212.0291.3437.1—

EPS IFRS 4 basis

260.6313.3———

EPS IFRS 17 basis (basic)

—220.0282.9445.1516.2

Diluted EPS IFRS 17 basis

——276.0435.4—

Dividend per share

100120125175230

Growth metric (%)

Growth metric (%)FY2023FY2024FY2025FY2026

NHE growth (FY2023 on IFRS 4; later years IFRS 17)

16274113

NHEPS growth (FY2023 on IFRS 4; later years IFRS 17)

19324618

DPS growth

2044031

Return / margin metric (%)

Return / margin metric (%)FY2022FY2023FY2024FY2025FY2026

Return on equity (NHE ÷ opening adjusted NAV)

——15.521.221.7

Return on embedded value per share

——13.319.122.3

VNB margin (VNB ÷ PVNBP)

——0.70.60.5

Operating profit ÷ NHE (quality of earnings proxy)

——81.387.684.6

Dividend payout of NHEPS (full year, derived)

34.835.140.438.843.4

Key Financials

New business metricFY2024FY2025FY2026

PVNBP (ZAR Mn)

82,14179,79393,800

VNB (ZAR Mn)

589469491

Recurring premiums (ZAR Mn)

4,1504,190—

Single premiums (ZAR Mn)

62,86560,139—

New business CSM (ZAR Mn)

1,6061,322—

Closing CSM (ZAR Mn)

19,39820,435—

Onerous contracts value (ZAR Mn)

—570349

Balance Sheet

Balance sheet metric (ZAR Mn)FY2024FY2025H1 FY2026 (31 Dec 2025)

Total assets

706,575802,823882,707

Total liabilities

676,518769,869848,828

Total equity

30,05732,95433,879

Per-Share Data and Financial Ratios (x)

Other balance sheet / capital metricFY2022FY2023FY2024FY2025

Diluted embedded value per share (ZAR)

—33.7536.9442.51

MML SAM solvency cover (times SCR, pre-foreseeable dividend)

2.032.072.101.96

Momentum Group SAM solvency cover (times SCR)

——1.651.58

Capital return metric

Capital return metricFY2022FY2023FY2024FY2025FY2026

Dividend per share (ZAR cents)

100120125175230

Share buybacks executed in year (ZAR Mn)

—500——1,600

Shares repurchased in year (millions)

—27.9——45

Margin Analysis (%) and Financial Ratios (x)

RatioFY2024FY2025FY2026

ROE (%)

15.521.221.7

ROA (NHE ÷ total assets, %, derived)

0.630.78—

Equity ÷ total assets (%, derived)

4.254.10—

Debt ÷ equity (%, third-party)

—30.9—

Interest coverage (times, third-party)

—6.5—

Revenue by Region

NHE by geography (ZAR Mn, derived)FY2024FY2025FY2026

South Africa and UK (all segments except Africa and India, incl. Shareholders)

4,3366,0396,651

Rest of Africa (Momentum Africa segment)

376288387

India (ABHI associate)

-274-6722

Group NHE

4,4386,2607,060

Share of group NHE by geography (%, derived)

Share of group NHE by geography (%, derived)FY2024FY2025FY2026

South Africa and UK

97.796.594.2

Rest of Africa

8.54.65.5

India

-6.2-1.10.3

PVNBP growth by segment (%)

PVNBP growth by segment (%)FY2026

Momentum Retail

8

Momentum Investments

16

Metropolitan Life

-14

Momentum Corporate

38

Momentum Africa

45

Group

18

VNB by segment (ZAR Mn)

FY2025

Momentum Retail

45

Momentum Investments

509

Metropolitan Life

-13

Momentum Corporate

-51

Momentum Africa

-21

Group VNB

469

PVNBP by segment (ZAR Mn)

FY2026

Momentum Retail

9,400

Momentum Investments

57,400

Metropolitan Life

5,600

Momentum Corporate

16,200

Momentum Africa

5,200

Group

93,800

JSE MTM share price (ZAR)

JSE MTM share price (ZAR)FY2021FY2022FY2023FY2024FY2025

Financial period-end share price

19.5014.2618.0622.9034.29

Price-return metric

Price-return metricValue

Recent price (11 Oct 2026, third-party)

About R36.90

52-week range (third-party)

About R32.88 – R42.90

Return since 30 Jun 2025 (about 15 months, approx.)

About +7.6%

1-year return (Fintel, as at 21 Aug 2026)

+11.4%

3-year return (from 30 Jun 2023, approx.)

About +104%

5-year return (from 30 Jun 2021, approx.)

About +89%

Valuation Multiples

MultipleMomentum GroupBasis

P/E (NHEPS)

About 7.0x

530c FY2026 NHEPS

P/E (HEPS)

About 7.0x

528.7c FY2026 HEPS

Price / embedded value

About 0.83x

—

Price / NAV (book)

About 1.4–1.5x

Sharedata snapshots (2026)

Dividend yield

About 6.2%

230c FY2026 DPS

EV/EBITDA, EV/Sales

Not meaningful for an insurer

—

Source Details

SourceIndicatorValue

Fintel (Aug 2026)

Average 1-year price target

R45.62

Simply Wall St (Sep 2026)

Analyst consensus target

R44.09

TradingView

Target range

R35.85 – R45.26

Coverage

Analysts covering

About 10–12

Dividend metric

Dividend metricFY2022FY2023FY2024FY2025FY2026

Interim DPS (ZAR cents)

—50—85110

Final DPS (ZAR cents)

—70—90120

Total DPS (ZAR cents)

100120125175230

Capital Programmes

ProgrammeSizeExecution

FY2023 interim programme

R500m

27.9m shares at R17.87 (43% discount to EV); completed 31 May 2023

FY2023 results programme

R500m

—

FY2024 results programme

R1bn

Completed (part of R2bn by 12 Sep 2025)

FY2025 interim programme

R1bn

29.1m shares at R34.42 (19% discount to EV)

FY2025 results programme

R1bn

27.4m shares at R36.45; completed 8 Apr 2026

New programme after FY2026

Not announced in the sources reviewed

—

Credit Ratings

AgencyEntityRatingOutlook

Moody's

Momentum Metropolitan Life Ltd

Insurance financial strength Ba1 (global); Aaa.za (national)

Linked to sovereign (South Africa Ba2).

Moody's (Dec 2020)

MML

Long-term issuer Ba2; subordinated debt Ba3(hyb)

Negative at that time (later stable per April 2022 opinion)

Fitch

Momentum / Metropolitan (historic)

AA(zaf) national IFS (circa 2012)

—

Analyst Conclusions

Management guidance

  • The F2027 ambitions are NHE of R7bn, ROE of 20% and a VNB margin of 1–2%. The first two have been met a year early; VNB is still short.

  • For FY2027, management expects the operating environment to remain difficult. It will sharpen its focus on VNB and on growing volumes and market share in profitable products, and it will deepen its use of AI and automation (FY2026 outlook, per Business Day).

  • It expects modest South African growth and continued affordability pressure. Lower inflation and falling rates should be a gradual tailwind.

  • A new strategy to FY2030 is due within 12 months.

  • The dividend policy targets a 50% payout of NHE within a 40–60% range.

Consensus growth expectations

  • Consensus earnings forecasts were not available in the sources reviewed.

  • Price targets of about R44–R46 imply roughly 20–24% upside from about R36.90.

  • Simply Wall St's community model references revenue growth of about 3.65% a year.

Bull case

  1. Compounding at a discount. At about 7x earnings and about 0.7–0.8x EV, with a 21.7% ROE and a 6%+ yield, continued buybacks below EV (R388m value uplift in FY2026) mechanically compound NHEPS ahead of NHE: +18% NHEPS vs +13% NHE in FY2026.

  2. Better earnings quality. Market variances fell 67% while operating profit rose 9%. Five units are each above R1bn, and the CSM is growing toward R21bn, which supports durable release.

  3. Health and non-life optionality. Bonitas and the GEMS extension give administration scale. Guardrisk earned R1.04bn and ABHI has turned profitable. These are growth engines outside the commoditised life market.

Bear case

  1. VNB is the real test. A 0.5% margin and VNB growth of only 5% on 18% more PVNBP suggest that new business is barely replacing value. The guaranteed-to-living annuity shift is structural, not cyclical, and Momentum Investments' VNB fell 30%.

  2. Earnings flattered by benign experience. FY2025–FY2026 benefited from positive assumption changes, a data-reserve release at Metropolitan, favourable mortality and low weather losses. A reversal (as in Corporate's mortality and Retail's yield variance in FY2026) could stall NHE growth near R7bn.

  3. Concentration and execution risk. Health administration now depends heavily on two very large schemes. The Bonitas go-live showed service strain and litigation noise, and a contract dispute or service failure could hurt earnings and reputation. Sovereign-capped ratings remain a structural ceiling.

Key catalysts and monitorables (next 12 months)

Catalyst / monitorableExpected timingWhy it matters
FY2026 AGM and any new buyback authorisationAbout Nov 2026Capital return trajectory
Q1 FY2027 operating updateAbout Nov 2026First read on VNB and Bonitas run-rate
H1 FY2027 interim resultsAbout Mar 2027VNB margin trend; Bonitas earnings contribution; Verso integration
Disclosure of FY2030 strategy and new targetsBy about Sep 2027Resets the investment case
Medscheme/Bonitas litigation and CMS investigation outcomeUncertainContract security
Guaranteed annuity volumes vs bond yieldsOngoingMain VNB driver
MML solvency cover vs 1.6–2.0x rangeQuarterlyCapacity for distributions
ABHI growth and IPO or partner actionsOngoingIndia value crystallisation (no transaction announced)
South African sovereign rating actionsOngoingRatings and cost of capital

Concluding analyst verdict

Momentum Group has delivered one of the clearest turnarounds in South African financial services over the past three years. On a consistent IFRS 17 basis, normalised headline earnings doubled from R3.49bn (FY2023 restated) to R7.06bn (FY2026). ROE moved from the mid-teens to 21.7%, and the dividend more than doubled from 100c (FY2022) to 230c. These gains did not come from one lucky line. Metropolitan Life went from chronic under-performer to R1.15bn of earnings. Momentum Insure went from a FY2024 loss-maker to R474m. Guardrisk passed R1bn. India turned positive. Cost discipline (R810m annualised savings) and steady buybacks below embedded value amplified the per-share outcome.

The market still prices the group at roughly 7x earnings and a discount to embedded value. That signals scepticism about whether the earnings base is sustainable, and the scepticism is partly justified. Value of new business, the purest measure of whether today's sales create tomorrow's profits, sits at a 0.5% margin, half the bottom of management's own target range. It is weighed down by a structural move from guaranteed to living annuities that is affecting the whole industry. Recent results also included supportive one-offs (assumption changes, reserve releases) and benign claims experience. The FY2026 Retail and Corporate declines show how quickly those can reverse.

On balance, Momentum is a high-return, cash-generative, capital-returning insurer whose valuation already reflects its VNB weakness. Its new growth sources are health administration scale, Guardrisk and India. The next 12 months hinge on three things. First, whether the FY2030 strategy credibly addresses new-business profitability. Second, whether Bonitas becomes a scale earnings contributor rather than a service liability. Third, whether buybacks continue at a meaningful discount to EV. If VNB margins move toward 1%, the discount looks too wide. If they do not, earnings likely plateau near R7–7.5bn and the shares remain a yield-and-buyback story rather than a growth re-rating.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Executive Leadership Team

NameTitleTenure (where verified)QualificationsPrior roles (verified)

Jeanette Marais

Group Chief Executive Officer; executive director

Group CEO since 2023 (GlobalData cites August 2023; predecessor retired late 2023)

BSc (Mathematics and Statistics), PED and MBA (cum laude), IMD Switzerland

Deputy CEO of the group; CEO of Momentum Investments; chair of MGIM board (2020)

Risto Ketola

Group Finance Director; executive director

Group CFO since June 2017

BSc, CFA, FIA, FASSA

Investor Relations and Business Performance Executive before 2017

Dumo Mbethe

CEO: Momentum Corporate; executive director

—

BCom (Accounting and Information Systems), BCom Hons, CA(SA), AMP (Harvard)

—

Lourens Botha

CEO: Guardrisk

—

BCompt Hons, CA(SA), Chartered Management Accountant

—

Lulama Booi

CEO: International

—

BCom (Accounting and Computer Science), BCom Hons, CA(SA)

—

Ravi Govender

Group Chief Digital and Technology Officer

—

MBChB, MSc Management

—

Johann le Roux

CEO: Momentum Advice and Distribution

Previously listed as CEO: Momentum Retail

BSc Hons (Mathematical Statistics), MBA, FASSA

CEO Momentum Retail

Jan Lubbe

Group Chief Risk Officer

—

MCom, MBA, CA(SA)

—

Njabulo Nyawo

Group Chief People Officer

—

BCom Hons, MBA, CA(SA)

—

Brand Pretorius

CEO: Momentum Insure

—

BCom Law, Advanced Management and Leadership Programme (Oxford)

—

Peter Tshiguvho

CEO: Metropolitan Life

—

BA (Psychology), MBA, CFP, AMP (Harvard)

—

Ferdi van Heerden

CEO: Momentum Investments

—

BSc (Hons) Mathematical Statistics, AMP (INSEAD), Dip Management (Henley), MCSI

CEO of Momentum UK / MGIM (2016–2020)

Stephen van Niekerk

CEO: Momentum Life

—

BCom (Hons), FIA, FASSA

—

Hannes Viljoen

CEO: Momentum Health

—

MChD (Public Healthcare), DHA, MBL

—

Board of Directors

DirectorRoleCommittee chairs (current)Appointed (where verified)Qualifications

Tyrone Soondarjee

Independent Chair

Nominations

INED 1 Jun 2023; interim chair 7 Nov 2025; Chair 18 Mar 2026

BAcc (Hons), PG Dip Auditing, CA(SA). Former CFO of Cell C, chair of Grindrod Bank, Group FD of Sasfin, Director of Finance at Deloitte; non-executive chair of Rentworks Holdings

Jeanette Marais

Group CEO

—

Executive

As above

Risto Ketola

Group FD

—

Executive

As above

Dumo Mbethe

Executive director (CEO Momentum Corporate)

——

As above

Linda de Beer

INED

Audit; Remuneration (from 1 Jun 2026)

—

CA(SA), MCom (Tax), Chartered Director

Nigel Dunkley

INED

Investments

—

BCompt Hons, CA(SA), AMP (Oxford)

Seelan Gobalsamy

INED

——

BCom (Accountancy and Law), PG Dip Accounting, CA(SA), AMP (Harvard)

Stephen Jurisich

INED

Actuarial; Fair Practices

—

BSc Hons (Actuarial Science), FASSA, FFA

Frannie Leautier

INED

(Remuneration chair until 31 May 2026)

1 Jun 2023

BSc, MSc, PhD (Engineering); Senior Partner, SouthBridge Group

Phillip Matlakala

INED

—

1 Jun 2023

B Juris, B Proc; former CEO of Metropolitan Retail (retired 2014)

Hillie Meyer

Non-executive (not independent; former Group CEO)

—

1 Apr 2024

BCom (Econometrics), FASSA; Momentum CEO 1996–2005; Group CEO 2018–2023

David Park

INED

Risk, Capital and Compliance

—

BSc (Actuarial Science), FASSA

Sharoda Rapeti

INED

Social, Ethics and Transformation

—

HND Electronic Engineering, MBA

Kobus Sieberhagen

INED

——

BA Hons, Masters and PhD (Clinical Psychology), AMP (Oxford)

Edwin Splinter

INED

——

BSc (Mathematics and Statistics), FASSA

Gcobisa Tyusha

Group Company Secretary

——

BCom; PG Dip Business Management

Board & Management Changes

DateChangeContext

1 Jun 2023

Leautier, Matlakala and Soondarjee appointed INEDs

Board skills refresh under chair Paul Baloyi

2023

Jeanette Marais becomes Group CEO

Succeeded Hillie Meyer on his retirement

1 Apr 2024

Hillie Meyer appointed non-executive director

Continuity and institutional knowledge

2024

Dan Moyane presented as non-executive chairman at the FY2024 results (September 2024)

—

7 Nov 2025

Paul Baloyi resigns as chair (left the board after the 20 Nov 2025 AGM); Soondarjee interim chair

No reason disclosed in the SENS

18 Mar 2026

Soondarjee confirmed Independent Chair

Continuity appointment

31 May / 1 Jun 2026

Soondarjee leaves the Audit and SET committees; Leautier steps down as Remuneration chair; Linda de Beer becomes Remuneration chair

Committee rebalancing

Major Shareholders

ShareholderStakeAs at / source

Public Investment Corporation (SOC) Ltd

15.70%

30 Oct 2024 (Profile's Stock Exchange Handbook 2025 Issue 3); about 16% per Simply Wall St (April 2025)

Government Employees Pension Fund

15.15%

Profile's Handbook 2025 Issue 1. GEPF assets are managed by the PIC, so this likely overlaps with the PIC line and should not be added to it

Kagiso Tiso Holdings (Pty) Ltd

About 7.9%

—

M&G Investment Managers (Pty) Ltd

—

Simply Wall St top holders list (Dec 2025)

The Vanguard Group

—

Same

Ninety One UK

—

Same

Sanlam Investment Management

—

Same

Coronation Fund Managers

—

Simply Wall St (OTC listing view)

Norges Bank Investment Management

—

Same

STANLIB Asset Management

—

Same

Momentum Asset Management / Momentum Multi-Manager (policyholder and client holdings)

—

Same

“—” = not publicly disclosed.

Competitive Landscape

Competitors by Segment

SegmentKey competitors

Individual life and savings (Momentum Retail)

Sanlam (Sanlam Personal Finance), Old Mutual (Mass and Foundation, Personal Finance), Discovery Life and Invest, Liberty (Standard Bank Group), BrightRock, PPS, Assupol (now part of Sanlam), Capitec Life

Mass-market life and funeral (Metropolitan Life)

Old Mutual Mass and Foundation Cluster, Sanlam (Assupol, Safrican), Clientele, Hollard, Capitec Life, AVBOB, retailer and bank-led funeral offerings

Platforms, annuities and asset management (Momentum Investments)

Allan Gray, Ninety One, Coronation, Glacier (Sanlam), Old Mutual Wealth, Discovery Invest, PSG/Ninety One platforms, Liberty/STANLIB; annuity writers including Sanlam, Old Mutual, Just Retirement (via partners)

Employee benefits (Momentum Corporate)

Old Mutual Corporate, Sanlam Corporate, Alexander Forbes, Liberty Corporate, NMG Benefits; the Verso acquisition adds administration capacity

Healthcare administration (Momentum Health)

Discovery Health (largest administrator), Medscheme (AfroCentric, Sanlam-aligned), Medihelp, other in-house scheme administrators

Specialist and cell-captive insurance (Guardrisk)

Centriq (Santam), Hollard (cell structures), Old Mutual Insure specialist, Sanlam/Santam specialist

Personal short-term insurance (Momentum Insure)

OUTsurance, Santam, Discovery Insure, Old Mutual Insure (iWYZE), King Price, Hollard, MiWay (Sanlam)

India health (ABHI)

Star Health and Allied, Niva Bupa, Care Health, ManipalCigna, multi-line general insurers

Africa

Sanlam (SanlamAllianz JV), Old Mutual, local insurers in Namibia, Botswana and Lesotho

Peer Comparison FY2025

MetricMomentum GroupSanlamOld MutualDiscovery

Fiscal year end

30 Jun 2026

31 Dec 2025

31 Dec 2025

30 Jun 2026

Core earnings measure

NHE R7.06bn

Net result from financial services R15.94bn; net operational earnings R17.15bn

Results from operations R9.82bn; adjusted headline earnings R8.26bn

Normalised headline earnings R11.80bn; normalised operating profit R17.75bn

Core earnings growth

+13%

NRFFS +3% (+20% normalised)

RFO +13%; AHE +24%

NHE +21%; normalised operating profit +17%

Life VNB

R491m

R2.29bn

Not compiled here

Not compiled here

VNB margin

0.5%2.01%1.2%

Not compiled here

PVNBP

R93.8bn

R113.9bn (life)

Not compiled here

Not compiled here

ROE / RoNAV

21.7% ROE

Not compiled here

15.2% RoNAV

15.4% normalised ROE (FY2025)

Embedded / equity value per share

About R44.55 EV (Dec 2025)

GEV R87.73

GEV R19.80

Not compiled here

Dividend per share (full year)

230c (+31%)

Not compiled here

93c (+8%)

384c (+33%)

R&D intensity

Not disclosed (not applicable)

———

“—” = not publicly disclosed.

Competitive Advantages & Vulnerabilities

AdvantagesVulnerabilities

Multi-brand coverage from mass market (Metropolitan) to affluent (Momentum) to corporate

Lowest VNB margin among peers; dependent on guaranteed annuity demand

Guardrisk's leadership in cell captives, with diversified non-life earnings

Third-party cell partners can in-source (Capitec precedent, 2024)

Health administration scale (GEMS + Bonitas), about 30% market share

Heavy concentration on two scheme clients; execution risk shown in Bonitas transition problems

Advice-led distribution (MFP, Consult, MDS, agency)

Agency-cost intensity; Metropolitan's volumes are falling

Strong capital position (MML SCR inside the 1.6–2.0x range); buyback capacity

Credit ratings capped by the South African sovereign

Highest ROE among peers

Earnings sensitive to yield-curve assumptions (R320m FY2026 Retail variance)

Recent Developments

Headcount reductions are implicit in Metropolitan Life's agency optimisation (tied agents −42% over FY2024–FY2026). Momentum Health staffed more than 600 roles for Bonitas.*

Company Snapshot

14,300

Employees

2000

Founded

Centurion, South Africa

Headquarters

SWOT Analysis

Strengths

  • Record, diversified earnings: FY2026 NHE R7.06bn (+13%); five units each above R1bn (Retail, Investments, Metropolitan, Corporate, Guardrisk); every unit profitable for the first time
  • Peer-leading return on equity: ROE 21.7% (FY2026), 21.2% (FY2025), above the 20% F2027 target and above Old Mutual's RoNAV of 15.2%
  • Strong capital generation and returns: DPS CAGR of 23% FY2022–FY2026; R1.6bn buybacks in FY2026; R2bn of programmes completed by Sept 2025; payout policy raised to 40–60%
  • Market-leading specialist non-life franchise: Guardrisk NHE R1.04bn (+26%); GGI underwriting result R828m; Guardrisk Life underwriting R244m
  • Health administration scale: About 30% administration market share; GEMS extended five years; Bonitas adds more than 750,000 beneficiaries
  • Demonstrated cost discipline: R810m annualised optimisation savings; direct expense growth of 3% in FY2026, below inflation
  • Large and growing CSM: CSM R20.4bn (FY2025) rising to R20.99bn (March 2026), giving visibility on future earnings release

Weaknesses

  • Sub-target new business profitability: VNB margin 0.5% vs 1–2% F2027 target; VNB R491m on PVNBP R93.8bn
  • Dependence on guaranteed annuities for VNB: Momentum Investments VNB −30% to R357m as guaranteed annuity volumes fell 26%
  • Earnings sensitivity to actuarial and market assumptions: R320m negative market variance in Retail from the ultimate spot-rate change; FY2025 earnings partly aided by favourable yield-curve shifts
  • Shrinking mass-market sales: Metropolitan PVNBP −14% (FY2026), −19% over FY2024–FY2026
  • Corporate earnings volatility: Momentum Corporate NHE −12% (reserve releases, continuation-assurance mortality); large-deal pricing pressure
  • Limited segment disclosure on restatements and geography: Unreconciled FY2025 comparatives for Health, Guardrisk and Africa; no geographic revenue split

Opportunities

  • Monetising health administration scale: Bonitas benefits of scale across the group (CEO, March 2026); positioning for possible public-private health reform
  • Wealth platform and living annuity growth: Wealth new business +24%; AUA +16% to R581bn; net inflows R20bn
  • Retail savings margin uplift: Retail VNB more than doubled (R45m to R98m); margin 0.5% to 1.0%
  • India becoming a contributor: ABHI from a −R274m (FY2024) loss to a +R22m (FY2026) profit; diversified growth
  • AI and automation productivity: R40m savings from seven AI use cases in H1 FY2026; planned expansion in FY2027
  • Bolt-on acquisitions and capital redeployment: Verso (2026), Control (FY2026), Zestlife/Admed (Guardrisk); next strategy to FY2030 within 12 months

Threats

  • Sovereign-linked ratings and balance sheet: Moody's: MML IFS Ba1, one notch above the South African sovereign (Ba2); ratings constrained by the sovereign
  • Bonitas execution and litigation: Medscheme sought to halt the transition; CMS investigation dispute; member service disruption after go-live
  • Concentration in health administration: GEMS and Bonitas are both very large single clients
  • Cell-captive partner in-sourcing: Capitec moved about 550,000 credit-life policies out of a Guardrisk Life cell in 2024
  • Household affordability and lapses: FY2026 outlook flags continuing affordability pressure; Metropolitan previously suffered high lapses (FY2024)
  • Weather and claims volatility in non-life: Momentum Insure lost about R300m in FY2024 on severe weather and service issues

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
4 and 9 Apr 2025CEO Jeanette Marais buys 22,000 shares on marketManagement confidence signal
14 May 2025Share buyback programme startsStart of R2bn of programmes completed by Sept 2025
Mid-2025Capital Markets Day previews revised dividend policy, capital deployment framework and efficiency programmeSets up the higher payout policy
9 Sep 2025Ghana exit concluded (Life, Pensions Trust, 85% of Health sold)Ends a 19-year presence; R1m disposal profit
12 Sep 2025R2bn of buybacks completed (latest tranche 29.1m shares at R34.42)Bought at a 19% discount to EV
17 Sep 2025FY2025 results: NHE +41% to R6.26bn; ROE 21.2%; DPS 175c (+40%); VNB −20%Record earnings; ROE target met early
17 Sep 2025Dividend policy raised to a 40–60% payout; further R1bn buyback approvedHigher cash returns
22 Sep 2025NED and former CEO Hillie Meyer buys 75,400 shares (about R2.5m)Insider buying
13 Oct 2025FY2025 final dividend of 90c paidCash return
13 Oct 2025Momentum Investments publishes its 2024 Stewardship ReportESG and stewardship disclosure
7–10 Nov 2025Chair Paul Baloyi resigns; Tyrone Soondarjee named interim chairGovernance transition
19 Nov 2025Q1 FY2026 update: PVNBP +8%; MML SCR cover 1.76x; Africa operating model changes in effectContinued earnings momentum
20 Nov 2025AGM; Baloyi leaves the boardGovernance
27 Nov and 1 Dec 2025FD Risto Ketola buys 10,000 sharesInsider buying
Jan 2026Bonitas awards administration to Momentum Health and managed care to PHA, effective 1 Jun 2026Largest administrator transfer in South Africa; market share from 22% to 30%
Early 2026 (reported 19 Mar 2026)GEMS main administrator contract extended five yearsAnchors health administration earnings
18 Mar 2026Soondarjee confirmed as Independent ChairBoard stability
19 Mar 2026H1 FY2026 results: NHE +8% to R3.695bn; NHEPS +12%; DPS 110c (+29%); PVNBP +11%; VNB −15%Steady growth; VNB weakness persists
19 Mar 2026Share price falls 3.7% to R32.92 on results dayMarket focus on VNB
Q1–Q2 2026Medscheme litigation to halt the Bonitas transition; removed from the urgent roll after procedural lapsesLegal noise around the contract
8 Apr 2026R1bn buyback completed (27m shares, average R36.54)Capital return
13 Apr 2026Interim dividend of 110c paidCash return
5 May 2026Board committee changes announced; Linda de Beer becomes Remuneration chair from 1 Jun 2026Governance
May 2026Q3 FY2026 update: 9-month NHE +15% to R5.54bn; NHEPS +20%; PVNBP +15%; CSM R20.99bn; MML SCR 1.81xRun-rate on track for the R7bn target
19 May 2026R1.5bn subordinated debt raisedBalance sheet optimisation as yields fell
1 Jun 2026Bonitas administration go-live with more than 600 staff and 17 service centresExecution milestone
Jun–Jul 2026Bonitas member service disruption and backlog; CMS investigation scope dispute between Bonitas and MedschemeReputational risk; the company says the backlog was largely resolved by results time
30 Jun 2026Momentum Mozambique Limitada classified as held for salePortfolio simplification
31 Aug 2026Sale of Momentum Mozambique Limitada concludedCompleted
17 Sep 2026FY2026 results: NHE +13% to R7.06bn; NHEPS +18% to 530c; ROE 21.7%; DPS 230c (+31%); PVNBP +18%; VNB +5%; all units profitable; five units above R1bnF2027 NHE target met a year early
17 Sep 2026India (ABHI) reports its first positive annual NHE contribution (R22m)Long-dated investment turning profitable
17 Sep 2026Dividend policy specifies a 50% target payout within 40–60%Policy clarity
Late Sep 20262026 Integrated Report publishedAnnual disclosure
25–30 Sep 2026Momentum Corporate acquires 100% of Verso Group (effective 1 Sep 2026; R26.25m for Vunani's 50%)Bolt-on in retirement administration
–FY2026 final dividend of 120c payableCash return

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

5 charts
Revenue by Segment: Momentum Retail to Guardrisk: Momentum Retail fell from ZAR 1,109 Mn in FY2024 to ZAR 1,010 Mn in FY2026.
Momentum Group Limited — Revenue by Segment: Momentum Retail to Guardrisk
Series (ZAR Mn)FY2024FY2025FY2026
Momentum Retail1,1091,3561,010
Momentum Investments5339631,190
Metropolitan Life5958681,148
Momentum Corporate1,1821,6181,420
Momentum Health255295367
Guardrisk6537751,040

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Sources

Sources

  1. Momentum Group FY2025 annual results SENS, 17 Sep 2025 (sharedata.co.za SENS id 525332; nsx.com.na mirror)
  2. Momentum Group H1 FY2026 interim results SENS, 19 Mar 2026 (sharedata.co.za SENS id 542427; nsx.com.na mirror) (senspdf.jse.co.za)
  3. Momentum Group Q1 FY2026 operating update, 19 Nov 2025 (nsx.com.na)
  4. Momentum Group Q3 FY2026 operating update, nine months to 31 Mar 2026 (momentumgroupltd.co.za; nsx.com.na)
  5. FY2024 results and operating update SENS, 27 Sep 2024 (senspdf.jse.co.za SENS_20240927_S495132 / S495133; sharedata.co.za)
  6. FY2024 trading statement, 6 Sep 2024 (senspdf.jse.co.za SENS_20240906_S494242)
  7. FY2023 results and operating update SENS, 13 Sep 2023 (senspdf.jse.co.za SENS_20230913_S479826 / S479827); company media release, 13 Sep 2023
  8. Change of name SENS: 24 May 2024, 1 Jul 2024, 4 Jul 2024 (senspdf.jse.co.za); Metropolitan "Part of Momentum Group" FAQ
  9. MMI to Momentum Metropolitan name change Q&A, 23 Jul 2019; Metropolitan change-of-name announcement, 12 Nov 2010
  10. Board SENS: 1 Jun 2023, 7 Mar 2024, 10 Nov 2025, 18 Mar 2026, 5 May 2026 (sharedata.co.za; nsx.com.na; senspdf.jse.co.za)
  11. Momentum Group website: executive committee, board of directors, environmental management pages (momentumgroupltd.co.za)
  12. Momentum Group Capital Markets Day finance presentation; Impact strategy update 2026; UK investor roadshow slides; MML debt investor roadshow 2026 (momentumgroupltd.co.za)
  13. Moody's credit opinion on Momentum Metropolitan Life (company-hosted); Moody's rating SENS, 2 Apr 2020, 26 Nov 2020, 17 Dec 2020
  14. Moonstone: FY2026 results analysis (21 Sep 2026); FY2025 results analysis; Q3 FY2026 analysis; Bonitas transition coverage; Verso acquisition (moonstone.co.za)
  15. Business Day / TimesLIVE: FY2026 results (17 and 19 Sep 2026); Soondarjee appointment (18 Mar 2026); Verso (30 Sep 2026)
  16. BusinessTech: FY2026 results; Ghana/Mozambique exits; Bonitas; FY2023 results; Capitec/Guardrisk (2024); Discovery FY2026
  17. Daily Investor: FY2026 results; Capitec/Guardrisk Life
  18. EWN: Momentum FY2026 results interview (17 Sep 2026)
  19. IOL Business Report: H1 FY2026 results (19 Mar 2026)
  20. FAnews: H1 FY2026 results release; Inniu acquisition (2021); Momentum Investments Stewardship Report (Oct 2025)
  21. AfroCentric statement on the Bonitas transfer
  22. Company media releases: Kenya exit (Jul 2022), Tanzania exit (Jun 2021), Zambia exit (Dec 2020), Seneca acquisition (Oct 2020), Guardrisk acquisition (2013/2014)
  23. Aditya Birla Capital and Business Standard: ADIA investment in ABHI (Aug–Oct 2022); SENS 23 Aug 2022
  24. WealthBriefing: MGIM acquisition of Crown Agents Investment Management (Apr 2023)
  25. International Adviser: London & Capital Adviser Solutions acquisition (2016)
  26. Profile's Stock Exchange Handbook 2025 Issues 1 and 3, 2026 Issues 1 and 2 (sharedata.co.za ebook)
  27. Sharedata MTM quote pages; Fintel; Simply Wall St (ownership, balance sheet health); TradingView; Traders Union (share price); Tracenable (employee data); GuruFocus (FY2024 results call summary); GlobalData executive profile
  28. Sanlam FY2025 annual results (sanlam.com, 12 Mar 2026); Old Mutual FY2025 annual results and presentation (17 Mar 2026); Discovery FY2025 results release and FY2026 results coverage
  29. Wikipedia: Momentum Group Limited (history and ownership context)

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.